Saturday, May 15, 2021
Home News Reports Glenmark starts phase-3 clinical trial for potential coronavirus drug ‘Favipiravir’ in India

Glenmark starts phase-3 clinical trial for potential coronavirus drug ‘Favipiravir’ in India

Favipiravir is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses, like the Novel Coronavirus

On Tuesday, Glenmark Pharmaceuticals said that it has initiated Phase-3 clinical trials of antiviral tablet Favipiravir, a potential drug for the Coronavirus after it received approval from the country’s drug regulator last month.

According to the reports, Glenmark is the first company in India to initiate Phase-3 clinical trials on Favipiravir for coronavirus patients in the country. Favipiravir is manufactured under the brand name Avigan by Fujifilm Toyama Chemical Co Ltd, a subsidiary of Japan’s Fujifilm Holdings Corporation. It was approved for use as an anti-flu drug in the country in 2014.

The drug company said that they have already started the clinical trials and more than 10 leading government and private hospitals in India are being enrolled for the study. It estimates the study completion by July or August this year.

Favipiravir is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses, like the Novel Coronavirus. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity. Favipiravir is effective against a wide range of types and subtypes of influenza viruses, including strains resistant to existing anti-influenza drugs.

It may be noted that favipiravir shows anti-viral activities against other RNA viruses such as arenaviruses, bunyaviruses and filoviruses, all of which are known to cause fatal hemorrhagic fever. These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.

To be commercialised under the name ‘FabiFlu’

The company said it has successfully developed API and the formulations for the product through its in house research and development team. The molecule will be marketed under the brand name ‘FabiFlu’ if commercialised in India.

Dr Monika Tandon, vice president and head of clinical development said, “Several health and medical experts, both in and outside of Glenmark, are eager to see the effect that Favipiravir has on COVID-19 cases. We believe the study results will be significant as there is currently no effective treatment for the virus”.

She added that the data they get from these trials will point us in a clearer direction with regard to coronavirus treatment and management.

“We believe the study results will be significant as there is currently no effective treatment for the virus. The data we get from these trials will point us in a clearer direction with regard to COVID-19 treatment and management,” Tandon said.

As per the approved clinical trial protocol, 150 subjects with mild to moderate coronavirus will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. The duration of the treatment is a maximum of 14 days and the total study duration will be a maximum of 28 days from randomisation.

  Support Us  

Whether NDTV or 'The Wire', they never have to worry about funds. In name of saving democracy, they get money from various sources. We need your support to fight them. Please contribute whatever you can afford

OpIndia Staffhttps://www.opindia.com
Staff reporter at OpIndia

Related Articles

Trending now

Journalists join hands with Congress trolls to spread propaganda against BJP over Delhi High Court ordered probe by police

Journalists blame BJP after Youth Congress president Srinivas B V questioned by Delhi Police on the orders of Delhi High Court

Read how RSS volunteers turned a defunct, British-era hospital, lying unused for over 2 decades, into a 200-bed COVID-19 facility

Volunteers of the Sangh Parivar, BJP and other organisations cleaned up the defunct KGF hospital in Karnataka to handle COVID-19 crisis

Massive Eid gatherings show the futility of lockdown during the second wave of the pandemic in India, it is time to lift them now

The Muslim community across the world is celebrating Eid ul-Fitr today. With it, the holy month of Ramadan comes to an end.

‘Delhi’s govt was just complaining, not trying to handle logistics of oxygen supply’: Director of INOX

Jain said that the central government's job is to inform these manufacturers to produce a certain amount of oxygen, which they did and made a chart for each state with specific volume allocation.

Dr.Reddy’s commences rollout of Russian-made Sputnik V vaccines, to be priced at Rs 995.40 per dose

Deepak Sapra, the global head of Custom Pharma Services at Dr Reddy's Lab became the first person to receive the Sputnik V shot at Hyderabad today.

Kejriwal govt sets aside Rs 50 crores for free vaccination of Delhi residents, while spending far more on PR: Details

While AAP government in Delhi spent Rs 150 crores on PR from Jan to March, it has only allocated Rs 50 crores for the free vaccination of Delhi's 2 crore population.

Recently Popular

Narcissism at its worse: After doubts were raised on the help being provided by Sonu Sood, actor gets called out for sharing cringe self-laudatory...

After making questionable claims on helping Covid-19 victims, Sonu Sood now shares cartoons that shows him as a God

Charlie Hebdo cartoon mocking Hindu deities for Covid-19 crisis turns out to be fake? Here’s what we know

Some social media users pointed out the hypocrisy of these 'left-liberals', who were just a few months back attacking the same French magazine for publishing cartoons that were allegedly hurtful for Muslims.

Israeli actress Gal Gadot, who once hailed ‘Shaheen Bagh dadi’, wishes for safety for Israel, gets hate from Islamists and ‘liberals’ in return

Gal Gadot's prayer for peace in her home country Israel irks up 'liberals' who even accused her of being a genocide enabler.

While Delhi govt was alleging inadequate oxygen supply, data show it was returning oxygen to suppliers, asked them to store the excess

Due to lack of storage plants and not enough demand, Delhi govt had returned oxygen and asked the suppliers to store them

Israel spy agency Mossad’s parody account pokes fun at Bollywood entertainer Swara Bhasker over her ‘#FreePalestine’ campaign

Swara Bhasker had posted a tweet calling Israel apartheid and terrorist state following the clashes at the Al Aqsa Mosque in Jerusalem
- Advertisement -

 

Connect with us

254,977FansLike
543,677FollowersFollow
24,300SubscribersSubscribe